← Kabir Nath

What podcasts say about Kabir Nath

Every statement, with the speaker, the exact quote and the moment it was said.

What Kabir Nath has said on podcasts

12 statements · 11 positive · 1 neutral

  1. on Psilocybin therapyPositiveNov 22, 2026· Motley Fool Hidden Gems Investing

    Two or three annual psilocybin sessions may relieve depression symptoms for up to a year

    “perhaps two or three day-long sessions in a year can give you relief from depression symptoms for up to a year”

    Listen at 0:09

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  2. on Natural psychedelic medicineNeutralNov 22, 2026· Motley Fool Hidden Gems Investing

    Natural psychedelic medicine settings will continue to exist

    “the natural medicine world is going to continue to exist”

    Listen at 23:23

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  3. on Natural psychedelic medicine infrastructure in Oregon and ColoradoPositiveNov 22, 2026· Motley Fool Hidden Gems Investing

    Natural psychedelic infrastructure will continue developing in Oregon and Colorado

    “I expect to see that continue to develop”

    Listen at 23:35

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  4. on SpravatoPositiveNov 22, 2026· Motley Fool Hidden Gems Investing

    Spravato is on track for a $3–3.5 billion annualized run rate

    “Spravato is on track to a three, three and a half billion dollar run rate”

    Listen at 24:20

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  5. Psychedelics will develop transformative market potential like immuno-oncology

    “I think you're going to see exactly the same with psychedelics”

    Listen at 25:59

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  6. on Psychedelic treatmentsPositiveNov 22, 2026· Motley Fool Hidden Gems Investing

    Psychedelic treatments will expand into currently untreated psychiatric conditions

    “you're going to see movement from some of the traditional neuropsych areas, where we've all started, into areas where there is nothing used today”

    Listen at 26:01

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  7. on Psychedelic treatments for OCD, eating disorders, and substance-use disordersPositiveNov 22, 2026· Motley Fool Hidden Gems Investing

    Potential psychedelic applications include OCD, eating disorders, and substance-use disorders

    “Obsessive compulsive disorder, eating disorders, substance use disorders, and so on”

    Listen at 26:11

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  8. Psychedelics will create a massive commercial opportunity

    “I think this will be a massive opportunity”

    Listen at 26:16

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  9. Compass may remain a leader in psychedelic medicine

    “I would hope the Compass continues to be a leader in that field”

    Listen at 26:18

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  10. on Psychedelic treatment centersPositiveNov 22, 2026· Motley Fool Hidden Gems Investing

    Psychedelic treatment centers will proliferate with varied operating models

    “you will see many, many different treatment centers, a range of different models”

    Listen at 26:39

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  11. on Psychedelic treatment-center infrastructurePositiveNov 22, 2026· Motley Fool Hidden Gems Investing

    Corporate investment will enter psychedelic treatment-center infrastructure

    “I think you're going to see a lot of corporate money coming into that side”

    Listen at 26:45

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know
  12. on Treatment-resistant depressionPositiveNov 22, 2026· Motley Fool Hidden Gems Investing

    Treatment-resistant depression may eventually cease to exist

    “this idea of treatment-resistant depression no longer exists”

    Listen at 27:01

    Open the episode · The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Kabir Nath: what podcasts say · PodLume